Levalbuterol Hydrochloride
- Product NDC
- 76204-003
- 11-digit product format
- 762040003
- Labeler code
- 76204
- Product ID
- 76204-003_f54c79f2-308f-4c04-8a6f-186fbc90bb8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levalbuterol Hydrochloride
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Ritedose Pharmaceuticals, LLC
- Application
- NDA020837
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2012-12-01
- Marketing end
- 0000-00-00
- Substance
- LEVALBUTEROL HYDROCHLORIDE
- Active strength
- 1 mg/3mL
- Pharmacologic classes
- Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 76204-003 | | I | Inactivated by FDA | | 2026-07-31 |
| excluded package | package | 76204-003 | 76204-003-24 | I | Inactivated by FDA | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| N020837-001 | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INHALATION | | RLD | 1999-03-25 |
| N020837-002 | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INHALATION | | RLD | 1999-03-25 |
| N020837-003 | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INHALATION | | RLD | 2002-01-30 |
| N020837-004 | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / INHALATION | | RLD | 2003-07-18 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 76204-003-24 | Levalbuterol Hydrochloride | 2 in 1 CARTON | SOLUTION | 2 | | 1 |
| 76204-003-24 | Levalbuterol Hydrochloride | 12 in 1 POUCH | SOLUTION | 12 | | 1 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76204-003 | LEVALBUTEROL HYDROCHLORIDE SOLUTION [RITEDOSE PHARMACEUTICALS, LLC] | 1 | Legacy NDC, 2 package rows | 20121227_6925ab5e-4f50-4d04-b55a-8a6f74474382.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 76204-003-24 | 76204000324 | 2 in 1 CARTON | Historical |